Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.08 -0.17 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Price to Earnings (2025 - 2026)

Updated

Xeris Biopharma Holdings' (XERS) Price to Earnings stood at 83.35 in Q1 2026, down 96.5% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Price to Earnings (2025 - 2026) Analysis & Trends

For FY2025, Xeris Biopharma Holdings' Price to Earnings came in at 2355.22.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xeris Biopharma Holdings 1.58 Bn 1.14 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 83.35
Dec 31, 2025 2,355.22
API Access

Xeris Biopharma Holdings Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=XERS&period=max&api_key=YOUR_API_KEY